Causes of mortality in schizophrenia: An updated review of European studies

Psychiatria Danubina

Volumn 29, Issue 2, 2017, Pages 108-120

  Piotrowski, Patryk ^a   Gondek, Tomasz M ^a   Królicka Derȩgowska, Anna ^a   Misiak, Błazej ^a   Adamowski, Tomasz ^a   Kiejna, Andrzej ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF LOWER SILESIA   (Poland)

Author keywords

Epidemiology; Life expectancy; Mortality; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MOOD STABILIZER; NEUROLEPTIC AGENT;

AGE; ARTERY DISEASE; BREAST CANCER; CEREBROVASCULAR DISEASE; DEINSTITUTIONALIZATION; DENMARK; FINLAND; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LUNG CANCER; MORTALITY; MORTALITY RATE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; OBESITY; PHYSICAL ACTIVITY; PSYCHOPHARMACOTHERAPY; REVIEW; RHEUMATIC HEART DISEASE; SCHIZOPHRENIA; SEX; SMOKING; STANDARDIZED MORTALITY RATIO; SUICIDE; SWEDEN; UNITED KINGDOM; VEIN DISEASE; ADULT; AGED; CAUSE OF DEATH; COMPARATIVE STUDY; CULTURAL FACTOR; EUROPE; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CAUSE OF DEATH; CROSS-CULTURAL COMPARISON; EUROPE; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE;

EID: 85023172538     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: 10.24869/psyd.2017.108     Document Type: Review

References (57)

1. Allebeck P: Schizophrenia: a life-shortening disease. Schizophr Bull 1989; 15:81-9.
2. Auquier P, Lançon C, Rouillon F & Lader M: Mortality in schizophrenia. Pharmacoepidemiol Drug Saf 2007; 16:1308-12.
3. Beary M, Hodgson R & Wildgust HJ: A critical review of major mortality risk factors for all-cause mortality in firstepisode schizophrenia: clinical and research implications. J Psychopharmacol 2012; 26(5 Suppl):52-61.
4. Brown S: Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171:502-8.
5. Brown S, Kim M, Mitchell C & Inskip H: Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010; 196:116-21.
6. Brown S & Mitchell C: Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort. Soc Psychiatry Psychiatr Epidemiol 2012; 47:843-7.
7. Bushe CJ, Taylor M & Haukka J: Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol 2010; 24(4 Suppl):17-25.
8. Castagnini A, Foldager L & Bertelsen A: Excess mortality of acute and transient psychotic disorders: comparison with bipolar affective disorder and schizophrenia. Acta Psychiatr Scand 2013; 128:370-5.
9. Chang CK, Hayes RD, Broadbent M, Fernandes A.C., Lee W., Hotopf M et al.: All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010; 10:77.
10. Chang CK, Hayes RD, Perera G, Broadbent M.T., Fernandes AC, Lee WE et al.: Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One 2011; 6:e19590.
11. Crump C, Winkleby MA, Sundquist K & Sundquist J: Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170:324-33.
12. Dean CE & Thuras PD: Mortality and tardive dyskinesia: long-term study using the US National Death Index. Br J Psychiatry 2009; 194:360-4.
13. De Hert M., Correll CU & Cohen D: Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophr Res 2010; 117:68-74.
14. Farr W: A report on the mortality of lunatics. J Stat Soc 1841; 4:17-33.
15. Fleischhacker WW, Kane JM, Geier J, Karayal O., Kolluri S, Eng SM et al.: Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial. J Clin Psychiatry 2014; 75:e184-90.
16. Hjortso S, Butler B, Clemmesen L., Jepsen PW, Kastrup M, Vilmar T et al.: The use of case vignettes in studies of interrater reliability of psychiatric target syndromes and diagnoses. A comparison of ICD-8, ICD-10 and DSM-III. Acta Psychiatr Scand 1989; 80:632-8.
17. Hoang U, Stewart R & Goldacre MJ: Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ 2011; 343:d5422.
18. Hoang U, Goldacre MJ & Stewart R: Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatr Scand 2013; 127:195-201.
19. Hodgson R, Wildgust HJ & Bushe CJ: Cancer and schizophrenia: is there a paradox? J Psychopharmacol 2010; 24(4 Suppl):51-60.
20. Høye A, Jacobsen BK & Hansen V: Increasing mortality in schizophrenia: are women at particular risk? A follow-up of 1111 patients admitted during 1980-2006 in Northern Norway. Schizophr Res 2011; 132: 228-32.
21. Kisely S, Sadek J, MacKenzie A., Lawrence D & Campbell LA: Excess cancer mortality in psychiatric patients. Can J Psychiatry 2008; 53:753-61.
22. Kodama S, Saito K, Tanaka S., Maki M, Yachi Y, Asumi M et al.: Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009; 301:2024-35.
23. Korkeila J, Lehtinen V, Bijl R., Dalgard O-S, Kovess V, Morgan A et al.: Establishing a set of mental health indicators for Europe. Scand J Public Health 2003; 31:451.
24. Laursen TM, Munk-Olsen T, Agerbo E., Gasse C & Mortensen PB: Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 2009; 66:713-20.
25. Laursen TM: Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011; 131:101-4.
26. Laursen TM, Munk-Olsen T & Gasse C: Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolaraffective disorder. PLoS One 2011; 6:e24597.
27. Laursen TM, Wahlbeck K, Hällgren J, Westman J., Ösby U, Alinaghizadeh H et al.: Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. PLoS One 2013; 8:e67133.
28. Laursen TM, Mortensen PB, MacCabe J.H., Cohen D & Gasse C: Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study. Psychol Med 2014; 44:1625-37.
29. Lewis G: Better information means better care, accessed 2 May 2014: http://www.england.nhs.uk/2014/01/15/geraint-lewis/
30. Mittoux A, Tanghøj P & Moore N: Exploring the potential prognostic effect of various country-specific health service data on all-cause mortality using data from a large prospective study in schizophrenia. Pharmacoepidemiol Drug Saf 2013; 22:925-32.
31. Mortensen PB & Juel K: Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163:183-9.
32. Newcomer JW: Metabolic syndrome and mental illness. Am J Manag Care 2007; 13(7 Suppl): S170-7.
33. Erratum in: Am J Manag Care 2008; 14:76.
34. Nielsen RE, Uggerby AS, Jensen SO & McGrath JJ: Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades - a Danish nationwide study from 1980 to 2010. Schizophr Res 2013; 146:22-7.
35. OECD: Strengthening Health Information Infrastructure for Health Care Quality Governance: Good Practices, New Opportunities and Data Privacy Protection Challenges, OECD Health Policy Studies, OECD Publishing, Paris. Accessed 17 May 2014: http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/strengthening-health-information-infrastructure-for-health-care-quality-governance-9789264193505-en#page2
36. Osborn DP, Levy G, Nazareth I., Petersen I, Islam A & King MB: Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007; 64:242-9.
37. Prince M, Patel V, Saxena S., Maj M, Maselko J, Phillips MR et al.: No health without mental health. Lancet 2007; 370:859-77.
38. Rantanen H, Koivisto AM, Salokangas R.K., Helminen M., Oja H, Pirkola S et al.: Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization. Soc Psychiatry Psychiatr Epidemiol 2009; 44:135-42.
39. Saha S, Chant D & McGrath J: A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64:1123-31.
40. Samele C, Frew S & Urquia N: Mental Health Systems in the European Union Member States, Sstatus of Mental Health in Populations and Benefits to be Expected from Investments Into Mental Health: European Profile of Prevention and Promotion of Mental Health (EuroPoPP-MH). European Commision, Executive Agency for Health and Consumers Tender, 2013.
41. Schmidt LM, Hesse M & Lykke J: The impact of substance use disorders on the course of schizophrenia-a 15-year follow-up study: dual diagnosis over 15 years. Schizophr Res 2011; 130:228-33.
42. Schoepf D, Potluri R, Uppal H., Natalwala A, Narendran P & Heun R: Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry 2012; 27:33-42.
43. Suvisaari J, Partti K, Perälä J, Viertiö S, Saarni SE, Lönnqvist J et al.: Mortality and its determinants in people with psychotic disorder. Psychosom Med 2013; 75:60-7.
44. Sykes FRS: Statistics of the metropolitan commission in lunacy. J Stat Soc 1840; 3:22-36.
45. Tabita B, de Santi MG & Kjellin L: Criminal recidivism and mortality among patients discharged from a forensic medium secure hospital. Nord J Psychiatry 2012; 66:283-9.
46. Talaslahti T, Alanen HM, Hakko H, Isohanni M., Häkkinen U & Leinonen E: Mortality and causes of death in older patients with schizophrenia. Int J Geriatr Psychiatry 2012; 27:1131-7.
47. Tenback D, Pijl B, Smeets H., Os Jv & Harten Pv: All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study. J Clin Psychopharmacol 2012; 32:31-5.
48. Tiihonen J, Lönnqvist J, Wahlbeck K., Klaukka T, Niskanen L, Tanskanen A et al.: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374:620-7.
49. Tiihonen J, Suokas JT, Suvisaari J.M., Haukka J., Korhonen P: Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 2012; 69:476-83.
50. Tran E, Rouillon F, Loze J.Y., Casadebaig F., Philippe A, Vitry F et al.: Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer 2009; 115:3555-62.
51. Vancampfort D, Rosenbaum S, Probst M., Soundy A, Mitchell AJ, De Hert M et al.: Promotion of cardiores-piratory fitness in schizophrenia: a clinical overview and meta-analysis. Acta Psychiatr Scand 2015; 132:131-43.
52. Vinogradova Y, Coupland C, Hippisley-Cox J, Whyte S & Penny C: Effects of severe mental illness on survival of people with diabetes. Br J Psychiatry 2010; 197:272-7.
53. Ward A: Privacy fears over NHS database in aid of medical research. Accessed 11 February 2014: http://www.ft.com/intl/cms/s/0/bc3a9962-8944-11e3-bb5f-00144feab7de.html
54. WHO: Leading causes of death in Europe: fact sheet, accessed 9 August 2015: http://www.euro.who.int/-data/assets/pdf-file/0004/185215/Leading-causes-of-death-in-Europe-Fact-Sheet.pdf
55. WHO: Global health risks: mortality and burden of disease attributable to selected major risks, Geneva, World Health Organization. Accessed 30 October 2016: http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report-full.pdf
56. WHO: Mental health action plan 2013-2020, accessed 19 July 2014, http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021-eng.pdf.
57. Yasamy MT, Cross A, McDaniell E & Saxena S: Living with Schizophrenia. Section V: Time to act. Living a healthy life with schizophrenia: paving the road to recovery. World Health Organization. Accessed: 30 October 2016: http://www.who.int/mental-health/world-mental-health-day/paper-wfmh.pdf